Cholangiocarcinoma

Known as: CC, Cholangiocarcinomas, Carcinoma, Cholangiocellular 
A carcinoma that arises from the intrahepatic biliary tree (intrahepatic cholangiocarcinoma) or from the junction, or adjacent to the junction, of… (More)
National Institutes of Health

Related topics

Related topics

46 relations
Abdominal PainBile Duct AdenocarcinomaBile Duct EpitheliumBile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma
(More)

Narrower (3)

Extrahepatic CholangiocarcinomaIntrahepatic CholangiocarcinomaKlatskin Tumor

Broader (5)

Gastrointestinal NeoplasmsGastrointestinal carcinomaMalignant neoplasm of gastrointestinal tractNeoplasms
(More)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Emerging molecular therapeutic targets for cholangiocarcinoma.
Cholangiocarcinomas (CCAs) are diverse epithelial tumors arising from the liver or large bile ducts with features of… (More)
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Exome sequencing of liver fluke–associated cholangiocarcinoma
Opisthorchis viverrini–related cholangiocarcinoma (CCA), a fatal bile duct cancer, is a major public health concern in areas… (More)
  • figure 1
  • table 5
Is this relevant?
Review
2011
Review
2011
Risk factors for cholangiocarcinoma.
Cholangiocarcinoma (CC) is the second most common primary hepatic malignancy after hepatocellular cancer. CC accounts for… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2011
Review
2011
Clinical diagnosis and staging of cholangiocarcinoma
Cholangiocarcinoma is the most frequent biliary malignancy. It is difficult to diagnose owing to its anatomic location, growth… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2011
Review
2011
Cholangiocarcinoma—controversies and challenges
Cholangiocarcinomas are a diverse group of tumors that are presumed to originate from the biliary tract epithelium either within… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.
BACKGROUND & AIMS Micro-RNA (miRNA) are endogenous regulatory RNA molecules that modulate gene expression. Alterations in miRNA… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.
1.0 GUIDELINES 1.1 Development of guidelines There is currently no clear national consensus for the optimal diagnosis and… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.
OBJECTIVE To analyze resectability and survival in patients with hilar cholangiocarcinoma according to a proposed preoperative… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism.
Chronic infection and inflammation are risk factors for the development of cholangiocarcinoma, a highly malignant, generally… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Extended resections for hilar cholangiocarcinoma.
OBJECTIVE To evaluate different strategies for extended resections of hilar cholangiocarcinomas on radicality and survival… (More)
  • table 1
  • table 2
  • figure 2
  • figure 1
  • figure 3
Is this relevant?